Frail survivors of childhood cancer experienced greater neurocognitive decline.
Survival improvements were noted in brain and nervous system cancers, colorectal cancers, and lung cancer.
For men and women with high genetic risk, five-year cancer incidence down significantly with a favorable lifestyle.
Living in rural counties and living farther from reporting hospital detrimental for adolescents and young adults with cancer.
Mandatory vaccination is especially crucial to protect vulnerable people, including unvaccinated children and those with weakened immune systems.
The findings support current management strategies for cancer patients, according to researchers.
Significant reductions seen for global distress index, psychological symptoms, physical symptoms of Memorial Symptom Assessment Scale.
Stereotactic body radiotherapy more than doubled the complete response rate.
Therapeutically actionable germline variants were found in 8% of patients with advanced cancers.
In 2020, an estimated 4.1 percent of all new cancer cases globally attributed to alcohol consumption.
72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening.
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
Decline especially noticeable among women of racial and ethnic minority groups with low incomes.
Decrease seen for 11 of the 19 most common cancers among men and for 14 of the 20 most common cancers among women.
Researchers observed a “sharp” decline in public interest.
Reduced risk for incident cancer and cancer-related mortality in patients with heart failure appears to depend on duration of statin use.
Efficacy differed by cancer type and KRAS status.
Nadir in pathology reports from GA, LA SEER registries seen in early April 2020, with 42.8 percent fewer reports compared with April 2019.
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs.
Researchers assessed the risk for all-cause mortality in cancer patients with COVID-19.